Cross-cultural Validation of the Japanese Version of the Lung Cancer Subscale on the Functional Assessment of Cancer Therapy-Lung

Saitoh, Erika; Yokomizo, Yuki; Chang, Chih‐Hung; Eremenco, Sonya; Kaneko, Hiromi; Kobayashi, Kunihiko

doi:10.1272/jnms.74.402

Cited by 13 publications

(14 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, 76.7% of the sample comprised patients treated and in remission from the underlying disease and, therefore, with better quality of life. When our FACT‐L results are compared with those from other studies using the same questionnaire, we find that there is great variability between countries and different cultures,2,3,7,22,24–27 which may be due to differing perceptions of the questions according to each culture and also differences in patient characteristics, such as staging, age, socioeconomic status, among others.…”

Section: Discussionmentioning

confidence: 71%

See 1 more Smart Citation

Reliability of the Brazilian version of the Functional Assessment of Cancer Therapy-Lung (FACT-L) and the FACT-Lung Symptom Index (FLSI)

Franceschini¹,

Jardim²,

Fernandes³

et al. 2010

Clinics

View full text Add to dashboard Cite

OBJECTIVES:The purpose of this study was to assess the reliability of the Brazilian version of the Functional Assessment of Cancer Therapy‐Lung (FACT‐L) with the FACT‐Lung Symptom Index (FLSI) questionnaire.INTRODUCTION:The assessment of quality of life in patients with lung cancer has become an important evaluative endpoint in current clinical trials. For lung cancer patients, one of the most common quality of life tools available is the FACT‐L. Despite the amount of data available regarding this questionnaire, there are no data on its performance in Brazilian lung cancer patients.METHODS:The FACT‐L with the FLSI questionnaire was prospectively administered to 30 consecutive, stable, lung cancer outpatients at baseline and at 2 weeks.RESULTS:The intraclass correlation coefficient between test and retest for the FACT‐L ranged from 0.79 to 0.96 and for the FLSI was 0.87. There was no correlation between these questionnaire dimensions and clinical or functional parameters.CONCLUSIONS:The Brazilian version of the FACT‐L with FLSI questionnaire is reliable and is quick and simple to apply. This instrument can now be used to properly evaluate the quality of life of Brazilian lung cancer patients.

show abstract

Section: Discussionmentioning

confidence: 71%

“…It has been translated and adapted into several languages and cultures 2,3,7,22,24–27. A feature of this instrument is the nonlinearity of the scores of its scales, a factor that complicates the interpretation of isolated study data.…”

Section: Discussionmentioning

confidence: 99%

Reliability of the Brazilian version of the Functional Assessment of Cancer Therapy-Lung (FACT-L) and the FACT-Lung Symptom Index (FLSI)

Franceschini¹,

Jardim²,

Fernandes³

et al. 2010

Clinics

View full text Add to dashboard Cite

show abstract

“…The patients’ health‐related QOL was measured with the Functional Assessment of Cancer Therapy‐Lung scale (FACT‐L). This scale assesses multiple dimensions of QOL during the past week: physical well‐being, social well‐being, emotional well‐being (EWB), functional well‐being (FWB), and lung cancer symptom burden (lung cancer subscale: LCS) . Higher scores indicate better QOL and lower symptom burden.…”

Section: Subjects Materials and Methodsmentioning

confidence: 99%

“…Scores of seven or greater indicate clinically significant psychological distress. The FACT‐L, SF‐8, and HADS have been validated in the Japanese population .…”

Section: Subjects Materials and Methodsmentioning

confidence: 99%

Prognostic Understanding at Diagnosis and Associated Factors in Patients with Advanced Lung Cancer and Their Caregivers

et al. 2018

View full text Add to dashboard Cite

This study demonstrated that substantial proportions of patients with newly diagnosed advanced lung cancer and their caregivers had misunderstandings about their prognosis. Accurate perceptions of prognosis, which are indispensable in the delivery of effective care, were associated with elevated levels of anxiety and depression in both patients and caregivers, warranting psychosocial care and support for them immediately after diagnosis. Inaccurate perceptions of prognosis in patients were associated with better emotional well-being and lower lung cancer-specific symptom burden. Illness understanding in caregivers was associated with patients' physical and mental status. Those findings provide insight into how they obtain accurate illness understanding.

show abstract

“…Simply adding cancer specific symptom items for a particular organ to FACT-G derives an organ-specific cancer QoL instrument, such as those for colon, lung and breast cancer [3]. These instruments have been validated and widely used in different populations internationally [5-7]. …”

Section: Introductionmentioning

confidence: 99%

Validation of the functional assessment of cancer therapy-gastric module for the Chinese population

Zhou

Yong

et al. 2012

Health Qual Life Outcomes

View full text Add to dashboard Cite

BackgroundQuality of life (QoL) assessment has become an important aspect of the clinical management of gastric cancer (GC), which poses a greater health threat in Chinese populations around the world. Functional Assessment of Cancer Therapy-Gastric Module (FACT-Ga), a questionnaire developed specifically to measure QoL of patients with GC, has never been validated in Chinese subjects. The current study was designed to examine the psychometric properties of FACT-Ga as a GC specific QoL instrument for its future use in Chinese populations.MethodsA sample of 67 Chinese patients with GC in the National University Hospital, Singapore was investigated cross-sectionally. The participants independently completed either English or Chinese versions of the FACT-Ga and the European Quality of Life-5 Dimensions (EQ-5D). Reliability was measured as the Cronbach’s α for EQ-5D, and five subscale scores and two total scores of FACT-Ga. The sensitivity to patients’ clinical status was evaluated by comparing EQ-5D and FACT-Ga scores between clinical subgroups classified by Clinical Stage and Treatment Intent. The construct validity of FACT-Ga was assessed internally by examining the item-to-scale correlations and externally by contrasting the FACT-Ga subscales with the EQ-5D domains.ResultsFor both FACT-Ga and EQ-5D, patients treated with curative intent rated their QoL higher than those treated for palliation, and early stage patients scored higher than those in the late stage. The sensitivity to clinical status of FACT-Ga scores were differential as four of seven FACT-Ga scores were significant for Treatment Intent while only one subscale score was significant for Clinical Stage. Six FACT-Ga scores had Cronbach’s α of 0.8 or above indicating excellent reliability. For construct validity, 45 of 46 items converged about their respective subscales. The monotrait-multimethod correlations between QoL constructs of FACT-Ga and EQ-5D were stronger than the multitrait-multimethod correlations as theoretically hypothesized, suggesting good convergent and discriminant validities.ConclusionsGiven the excellent reliability and good construct validity, FACT-Ga scores are able to distinguish patient groups with different clinical characteristics in the expected direction. Therefore FACT-Ga can be used as a discriminative instrument for measuring QoL of Chinese patients with GC.

show abstract

Cross-cultural Validation of the Japanese Version of the Lung Cancer Subscale on the Functional Assessment of Cancer Therapy-Lung

Abstract: Ta b l e 1 P a t i e n t C h a r a c t e r i s t i c s ( n＝ 1 8 0 ) n C a t e g o r y Va r i a b l e

Cited by 13 publications

References 10 publications

Reliability of the Brazilian version of the Functional Assessment of Cancer Therapy-Lung (FACT-L) and the FACT-Lung Symptom Index (FLSI)

Reliability of the Brazilian version of the Functional Assessment of Cancer Therapy-Lung (FACT-L) and the FACT-Lung Symptom Index (FLSI)

Prognostic Understanding at Diagnosis and Associated Factors in Patients with Advanced Lung Cancer and Their Caregivers

Validation of the functional assessment of cancer therapy-gastric module for the Chinese population

Contact Info

Product

Resources

About